ClariVest Asset Management’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-257
Closed -$6K 878
2020
Q2
$6K Buy
+257
New +$5.88K ﹤0.01% 617
2018
Q1
Sell
-57,025
Closed -$2.18M 785
2017
Q4
$2.18M Sell
57,025
-3,700
-6% -$148K 0.04% 332
2017
Q3
$2.28M Sell
60,725
-23,568
-28% -$832K 0.05% 273
2017
Q2
$3.14M Sell
84,293
-9,705
-10% -$351K 0.08% 226
2017
Q1
$3.69M Buy
93,998
+57,982
+161% +$2.18M 0.09% 203
2016
Q4
$1.25M Sell
36,016
-35
-0.1% -$1.37K 0.03% 309
2016
Q3
$1.42M Buy
+36,051
New +$1.44M 0.04% 261
2016
Q1
Sell
-70,522
Closed -$3.39M 682
2015
Q4
$3.39M Sell
70,522
-2,815
-4% -$130K 0.1% 122
2015
Q3
$2.89M Sell
73,337
-8,253
-10% -$351K 0.09% 142
2015
Q2
$3.47M Sell
81,590
-24,912
-23% -$993K 0.1% 137
2015
Q1
$4.2M Sell
106,502
-3,325
-3% -$123K 0.13% 109
2014
Q4
$3.96M Sell
109,827
-10,779
-9% -$362K 0.14% 94
2014
Q3
$3.56M Buy
120,606
+24,245
+25% +$669K 0.13% 104
2014
Q2
$2.42M Sell
96,361
-4,795
-5% -$119K 0.09% 147
2014
Q1
$2.61M Buy
101,156
+18,480
+22% +$466K 0.11% 140
2013
Q4
$1.86M Buy
82,676
+81,665
+8,078% +$1.58M 0.08% 162
2013
Q3
$14K Buy
+1,011
New +$13.5K ﹤0.01% 462

Other funds holding NTUS

ClariVest Asset Management's NTUS Position: Q3 2020 in Review

ClariVest Asset Management sold out of Natus Medical Inc (NTUS) in Q3 2020, closing a stake of 257 shares — an estimated $6K sold.

ClariVest Asset Management first reported a position in NTUS in Q3 2013 and held it in 17 quarters. The position peaked at $4.2M in Q1 2015. 159 funds tracked by Wall St. Rank hold NTUS as of Q3 2020.

  • ClariVest Asset Management reported no remaining Natus Medical Inc position as of Q3 2020 after selling out during the quarter.
  • ClariVest Asset Management sold 257 Natus Medical Inc shares in Q3 2020, an estimated $6K.
  • ClariVest Asset Management first reported a position in Natus Medical Inc in Q3 2013 and held it in 17 quarters.
  • ClariVest Asset Management's Natus Medical Inc position peaked at $4.2M in Q1 2015.
  • 159 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2020.

Based on ClariVest Asset Management's 13F filing for Q3 2020, filed 9 Nov 2020.